Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA‐A2/Mage3 complex density using a high‐affinity TCR like monoclonal antibody

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Immunology

• Publication date

  2005-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.200526307PMID 16163672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Part I: Vaccines for solid tumours.

  2004cited by this paper
• Dissecting cytotoxic T cell responses towards the NY‐ESO‐1 protein by peptide/MHC‐specific antibody fragments

  2004cited by this paper
• T cell killing does not require the formation of a stable mature immunological synapse

  2004cited by this paper
• Lipid Rafts Mediate Association of LFA-1 and CD3 and Formation of the Immunological Synapse of CTL1

  2004cited by this paper
• The cancer/testis genes: review, standardization, and commentary.

  2004cited by this paper
• Modification of peptide interaction with MHC creates TCR partial agonists.

  2004cited by this paper
• Intravenous Injection of a Lentiviral Vector Encoding NY-ESO-1 Induces an Effective CTL Response1

  2004cited by this paper
• Quantitating protein synthesis, degradation, and endogenous antigen processing.

  2003cited by this paper
• Recombinant antibodies with MHC‐restricted, peptide‐specific, T‐cell receptor‐like specificity: new tools to study antigen presentation and TCR–peptide–MHC interactions

  2003cited by this paper
• Genetic engineering of T cell specificity for immunotherapy of cancer.

  2003cited by this paper
• Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides.

  2003cited by this paper
• Direct Phenotypic Analysis of Human MHC Class I Antigen Presentation: Visualization, Quantitation, and In Situ Detection of Human Viral Epitopes Using Peptide-Specific, MHC-Restricted Human Recombinant Antibodies1

  2003cited by this paper
• Antigen Density Presented By Dendritic Cells In Vivo Differentially Affects the Number and Avidity of Primary, Memory, and Recall CD8+ T Cells 1

  2003cited by this paper
• Rational peptide-based tumour vaccine development and T cell monitoring.

  2003cited by this paper
• TCRs with high affinity for foreign pMHC show self-reactivity

  2003cited by this paper
• Tax and M1 Peptide/HLA-A2-Specific Fabs and T Cell Receptors Recognize Nonidentical Structural Features on Peptide/HLA-A2 Complexes 1

  2003cited by this paper
• Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation.

  2003cited by this paper
• Pre-Existing Immunity to Tyrosinase-Related Protein (TRP)-2, a New TRP-2 Isoform, and the NY-ESO-1 Melanoma Antigen in a Patient with a Dramatic Response to Immunotherapy

  2002cited by this paper
• Antimelanoma Activity of CTL Generated from Peripheral Blood Mononuclear Cells After Stimulation with Autologous Dendritic Cells Pulsed with Melanoma gp100 Peptide G209-2M Is Correlated to TCR Avidity

  2002cited by this paper
• Modification of a Tumor-Derived Peptide at an HLA-A2 Anchor Residue Can Alter the Conformation of the MHC-Peptide Complex: Probing with TCR-Like Recombinant Antibodies1

  2002cited by this paper
• Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

  2002cited by this paper
• A listing of human tumor antigens recognized by T cells

  2001cited by this paper
• Identification of New Epitopes from Four Different Tumor-Associated Antigens: Recognition of Naturally Processed Epitopes Correlates with HLA-A∗0201-Binding Affinity1

  2001cited by this paper
• Class I Major Histocompatibility Complex Anchor Substitutions Alter the Conformation of T Cell Receptor Contacts*

  2001cited by this paper
• Critical Role for CD8 in Binding of MHC Tetramers to TCR: CD8 Antibodies Block Specific Binding of Human Tumor- Specific MHC-Peptide Tetramers to TCR1

  2001cited by this paper
• Manipulation of Avidity to Improve Effectiveness of Adoptively Transferred CD8+ T Cells for Melanoma Immunotherapy in Human MHC Class I-Transgenic Mice1

  2001cited by this paper
• Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.

  2001cited by this paper
• The Density of Peptides Displayed by Dendritic Cells Affects Immune Responses to Human Tyrosinase and gp100 in HLA-A2 Transgenic Mice1

  2000cited by this paper
• Determination of the Relationship Between T Cell Responsiveness and the Number of MHC-Peptide Complexes Using Specific Monoclonal Antibodies1

  2000cited by this paper
• Tetramer-Guided Analysis of TCR β-Chain Usage Reveals a Large Repertoire of Melan-A-Specific CD8+ T Cells in Melanoma Patients1

  2000cited by this paper
• Human tumor antigens for cancer vaccine development

  1999cited by this paper
• Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

  1999cited by this paper
• Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

  1998cited by this paper
• Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody.

  1997cited by this paper
• Analogues of CTL epitopes with improved MHC class‐I binding capacity elicit anti‐melanoma CTL recognizing the wild‐type epitope

  1997cited by this paper
• An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex

  1996cited by this paper
• Generation of cytotoxic T‐cell responses with synthetic melanoma‐associated peptides in vivo: Implications for tumor vaccines with melanoma‐associated antigens

  1996cited by this paper
• Magnetofluorescent liposomes for increased sensitivity of immunofluorescence.

  1995cited by this paper
• A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3

  1994cited by this paper
• Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays.

  1994cited by this paper
• HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

  1992cited by this paper
• Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis

  1991cited by this paper
• Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation

  1990cited by this paper
• Clonal expansion of lymphocytes bearing the gamma delta T-cell receptor in a patient with large granular lymphocyte disorder.

  1989cited by this paper
• T cell growth factor receptors. Quantitation, specificity, and biological relevance

  1981cited by this paper
• Quantitation, Specificity, and Biological Relevance*

  1981cited by this paper

• CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivo.

  2025cites this paper
• TCR-like antibodies targeting autoantigen-mhc complexes: a mini-review

  2022cites this paper
• Mechanosurveillance: Tiptoeing T Cells

  2022cites this paper
• Therapeutic bispecific antibodies against intracellular tumor antigens.

  2022cites this paper
• T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy

  2021cites this paper
• Utilising molecular dynamics simulations to understand and engineer T-cell receptors

  2020cites this paper
• Targeting the MHC Ligandome by Use of TCR-Like Antibodies

  2019influential citation
• TCR-like antibodies in cancer immunotherapy

  2019cites this paper
• Opportunities and Challenges for Antibodies against Intracellular Antigens

  2019cites this paper
• T-cell receptor mimic (TCRm) antibody therapeutics against intracellular proteins

  2019cites this paper
• MAGE-A antigens as targets for cancer immunotherapy.

  2018cites this paper
• Therapeutic Antibodies against Intracellular Tumor Antigens

  2017cites this paper
• Mechanosensing drives acuity of αβ T-cell recognition

  2017influential citation
• Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H

  2014cites this paper
• Engineering T Cells to Target Tumor Cells

  2014cites this paper
• 213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

  2013cites this paper
• T-Cell Receptor-Like Antibodies: Targeting the Intracellular Proteome Therapeutic Potential and Clinical Applications

  2013cites this paper
• T-cell-receptor-like antibodies – generation, function and applications

  2012cites this paper
• An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.

  2011cites this paper
• Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors

  2011cites this paper
• COMBODY: one‐domain antibody multimer with improved avidity

  2010cites this paper
• High affinity soluble ILT2 receptor: a potent inhibitor of CD8+ T cell activation

  2010cites this paper
• Evidence of Extranuclear Cell Sensitivity to Alpha-Particle Radiation Using a Microdosimetric Model. II. Application of the Microdosimetric Model to Experimental Results

  2009cites this paper
• Antibody Targeting to a Class I MHC-Peptide Epitope Promotes Tumor Cell Death

  2006cites this paper
• Death MHC-Peptide Epitope Promotes Tumor Cell Antibody Targeting to a Class I

  2006cites this paper